800-526-2125
Status™ COVID-19/Flu A&B
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens
- COVID-19
- Anterior nasal swab specimen − Sensitivity 93.8 %, Specificity 100%
- Nasopharyngeal − Sensitivity 93.1 %, Specificity 100%
- Flu A - Sensitivity 91.4%, Specificity 95.7%
- Flu B - Sensitivity 87.6%, Specificity 95.9%
- FDA Emergency Use Authorization (EUA)
- Visually read in 15 minutes
- Flocked nasopharyngeal swab for superior specimen collection and patient comfort
| ORDERING INFORMATION | ||
|---|---|---|
| PRODUCT | # OF TESTS | ITEM # |
| Status™ Covid-19/Flu A&B | 25 | 33225 |
